Press Releases

British drug-maker GlaxoSmithKline (GSK) has submitted a marketing authorisation application to the European Medicines Agency (EMA) seeking an additional indication for eltrombopag (Revolade). The application was filed for additional indication of the drug to treat adult...

Cologne, Germany, November 12, 2014 / B3C newswire / -New Oncology announced today that it has entered into a collaboration with the National Cancer Centre Singapore (NCCS). Under this agreement, New Oncology will apply its proprietary diagnostic platform ‘NEO’...

Zurich, Switzerland, November 10, 2014 / B3C newswire / - Haselmeier was able to successfully grow over the past few years, allowing the company to carve out a solid position in the market for medical devices. In keeping with...

Novasep Varicol high-performance continuous chromatography technology brings productivity gains in an Indian-based API commercial production Novasep, a leading supplier of manufacturing solutions to the life sciences industry, and its long-time partner Nilsan Nishotech Systems, a specialist...

Valbonne, France, November 7, 2014. – TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, economically viable, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Damian...

TxCell (FR0010127662 - TXCL), a biotechnology company developing innovative, economically viable, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today reports its revenues(1) as of September 30, 2014. ...

CARLINA Technologies, a biotechnology company specialized in the development of nanomedicines, today announces the signing of a collaborative agreement with GenBiotech for the development of a prolonged-release pharmaceutical form of a protein. The resultant protein will be used in...